Fact CheckerSign in

NCT06931496Not yet recruiting

Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy

Source: ClinicalTrials.gov · Last updated 17 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The investigators are interested here in the contribution of a new prostate cancer screening method and, more specifically, in the new and somewhat futuristic approach of artificial intelligence in the development of new, more accurate algorithms that make it possible to rethink the benefits of mass generalisation of prostate biopsies. Main objective The main objective of this research is to use artificial intelligence and an associated algorithm to identify new indicators that would make it possible to avoid a prostate biopsy in patients with an initial suspicion of prostate cancer.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
8 Apr 2025
Start date
15 Apr 2025
Primary completion date
1 Sept 2025
Lead sponsor
Central Hospital, Nancy, France
NCT number
NCT06931496

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 15 Apr 2025 to the primary completion date, 1 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who have already had a prostate biopsy
  • Patients under court protection, guardianship or trusteeship
  • Patients deprived of liberty by judicial or administrative decision

Who the study is looking for

  • Patients followed up at the Nancy CHRU in the Urology Department and eligible for a prostate biopsy in search of prostate cancer, taking into account an increase in PSA, PSA density, lesion on MRI.
  • Person who has received full information about the organisation of the research and has not objected to their participation and the use of their data.
  • Adult male over 18 years of age - Patient affiliated to or benefiting from a social security scheme - Patient who understands French and is able to fill in a self-administered questionnaire or who has the possibility to be assisted in filling it in.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHRU Nancy
Coordinator of this site? Confirm its status
Vandœuvre-lès-NancyFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.